Glyclean® D70, The Future of Hard Surface Disinfection
Glycolic Acid Disinfectants
The demand for disinfectants and sanitizers continues to rise while some active chemicals are receiving scrutiny for potential health and environmental concerns. Are you looking for a new active ingredient to add to your portfolio?
Look no further; Glyclean® D was developed to meet the current and future market needs for hard surface disinfection.
What is Glyclean® D70?
Glyclean® D70 is a glycolic-acid-based EPA registered (EPA registrations number: 71654-31) disinfectant from PureTech Scientific, previously by Chemours, that offers broad-spectrum disinfectant claims. It is registered as a manufacturing-use-only product and available for use through sub-registration. Glyclean® D70 has four registered formulations in the United States and one in Europe for hard-surface cleaning and sanitization.
Watch this video to learn about Glyclean® D70, The Future of Hard Surface Disinfection.
Why is Glyclean® the Future of Surface Disinfection?
Naturally occurring, readily biodegradable
Excellent performing disinfectant with a positive chemical profile
Cleans and disinfects in one step
Safe for use in designated disinfection applications
Available for use in EPA-registered formulations designed to meet future regulations
Low VOC, safer for people and the environment
Attacks microorganism cell walls/membranes and disrupts essential cellular functions
Dual mode of action minimizes the chance of organisms developing resistance
No need to pre-clean surfaces prior to disinfection
An acid cleaning solution that sequesters and solubilizes multivalent metals
Glyclean® D70 Disinfection and Antimicrobial Activity
Mode of Action: Glyclean® D70 utilizes its small molecular size and dual functional groups (COOH and OH) to provide a multi-mode of action for microbial cell disruption. As a result of this duality of action, the development of microbial resistance is dramatically minimized with the use of Glyclean® disinfectants.
Bactericidal Activity: Glyclean® D70 kills a very wide range of both Gram-positive and Gram-negative bacteria. Glyclean® D70 has demonstrated efficacy against E.coli (including O157:H7), Listeria welshimeri, Pseudomonas, Salmonella, and Staphylococcus. Full EN 13697 studies are available for review.
Viricidal Activity: Glyclean® D70 is an effective viricidal agent as well. Various studies have demonstrated that Glyclean® D70 effectively kills both large and small viruses and both enveloped and non-enveloped viruses. Testing has shown efficacy against SARS-CoV-2 (COVID-19), Influenza type A, Rhinovirus type 37, and Herpes type 1.
Glyclean® Bactericidal, Viricidal, and Fungicidal Efficacy
PureTech Scientific Glyclean® D70 has been registered with the US EPA as an active ingredient in the formulation of disinfectants on hard, nonporous surfaces for household, industrial, institutional, or commercial use. A range of Glyclean® D clean-and-disinfect formulated products for hard surfaces have also been registered with the US EPA and are available for sub-registration purposes.
Glyclean® D70 may also be used in formulating disinfecting cleaners for use in agricultural premises and food processing facilities, as well as on food processing equipment. Label directions on the end-use product must specify that all food, feed, and animals be removed before application and that a potable water rinse must follow the application.
In the EU, PureTech Scientific is fully committed to completing the BPR process, and Glyclean® D is used in formulations for National Registrations. The BPR process provides a transition period that supports registering new formulations with Glyclean® D.
Glyclean® D showed excellent efficacy against a broad range of bacteria and viruses, including SARS-CoV-2, the cause of COVID-19, at a (> 99.9) kill rate in one minute. Details describing the bactericidal, viricidal, and fungicidal efficacy of Glyclean® are shown in the tables below. The results reported herein were performed by third-party contract laboratories:
Glyclean® North American Studies
Summary of Glyclean® D70 Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
E. coli
AOAC 955.14; 964.02
5.0%
>99.999
E. coli O157:H7
AOAC 955.14; 964.02
5.0%
>99.999
Listeria mono.
AOAC 955.14; 964.02
5.0%
>99.999
Listeria welsh.
AOAC 955.14; 964.02
5.0%
>99.999
Pseudomonas aer.
AOAC 955.14; 964.02
5.0%
>99.999
Salmonella Chol.
AOAC 955.14; 964.02
5.0%
>99.999
Salmonella typ.
AOAC 955.14; 964.02
5.0%
>99.999
Staphylococcus aur.
AOAC 955.14; 964.02
5.0%
>99.999
Herpes Simplex 1
EPA DIS/TSS-7
5.0%
>99.99
Influenza A-2
EPA DIS/TSS-7
5.0%
>99.99
Rhinovirus Type 37
EPA DIS/TSS-7
5.0%
>99.99
SARS-CoV-213
ocspp 810.2200
5.5%
>99.99
Summary of Broad-Spectrum Disinfectant and Cleaner Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
SARS-CoV-2
ocspp 810.2200
5.5%
>99.99
Pseudomonas aer.
ocspp 810.2200
5.5%
>99.99
Salmonella ent.
ocspp 810.2200
5.5%
>99.99
Staphylococcus aur.
ocspp 810.2200
5.5%
>99.99
Summary of Hard Surface Cleaner Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
SARS-CoV-2
ocspp 810.2200
5.0%
>99.99
E. coli
AOAC 955.14; 964.02
5.0%
>99.999
Pseudomonas aer.
AOAC 955.14; 964.02
5.0%
>99.999
Salmonella Chlor.
AOAC 955.14; 964.02
5.0%
>99.999
Staphylococcus aur.
AOAC 955.14; 964.02
5.0%
>99.999
Herpes Simplex 1
EPA DIS/TSS-7
5.0%
>99.999
Influenza A-2
EPA DIS/TSS-7
5.0%
>99.999
Rhinovirus Type 37
EPA DIS/TSS-7
5.0%
>99.999
Summary of Pine Cleaner Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
Salmonella ent.
EPA DIS/TSS-7
2.1%
>99.999
Staphylococcus aur.
AOAC 955.14; 964.02
2.1%
>99.999
Influenza A
AOAC 955.14; 964.02
2.1%
>99.999
Summary of Toilet Bowl Cleaner Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
E. coli
AOAC 955.14; 964.02
9.5%
>99.999
Pseudomonas aer.
AOAC 955.14; 964.02
9.5%
>99.999
Salmonella ent.
AOAC 955.14; 964.02
9.5%
>99.999
Staphylococcus aur.
AOAC 955.14; 964.02
9.5%
>99.999
Herpes Simplex 1
EPA DIS/TSS-7
9.5%
>99.999
Influenza A-2
EPA DIS/TSS-7
9.5%
>99.999
Rhinovirus Type 37
EPA DIS/TSS-7
9.5%
>99.999
Glyclean® European Efficacy Studies
Summary of Hard Surface Cleaner and Disinfectant Efficacy Studies
Species
Guideline
Wt % Acid
% Reduction
Enterococcus hirae
UNE-EN 1276; 13697
80%; 75%
>99.9999
E. coli
UNE-EN 1276; 13697
80%; 75%
>99.9999
Pseudomonas aer.
UNE-EN 1276; 13697
80%; 75%
>99.9999
Staphylococcus aur.
UNE-EN 1276; 13697
80%; 75%
>99.9999
Aspergillus brasil.
UNE-EN 13697; A1
Full Strength
>99.9999
Candida albicans
UNE-EN 1650
60%
>99.9999
Adenovirus
NF EN 14476; A2
20%
>99.9999
Murine norovirus
NF EN 14476; A2
20%
>99.9999
Poliovirus
NF EN 14476; A2
20%
>99.9999
Summary of Broad-Spectrum Disinfectant and Cleaner Efficacy Studies
Glyclean® D is a family of disinfecting products based upon the natural power of glycolic acid. Glycolic acid is the smallest of the fruit acids and is found in a wide variety of produce we eat daily. Its small size and unique chemistry make it a highly effective and efficient antimicrobial agent that is easy on the environment. PureTech Scientific glycolic acid, previously manufactured by Chemours, is identical to the glycolic acid found in nature; it is synthesized similar to Glypure™ and other PureTech Scientific glycolic acid products by a highly efficient production process in the United States.
US EPA FIFRA Registrations
In the United States, PureTech Scientific supports the raw material EPA registration under FIFRA for glycolic acid. In addition, multiple product formulations are registered under FIFRA for sub-registration opportunities. Glyclean® D70 has been approved for killing the SARS-CoV-2 virus, the cause of the COVID-19 pandemic. In addition, the Hard Surface Cleaner formulation label is registered with the US EPA and the California EPA for label claims against killing the SARS-CoV-2 virus.
Global Registrations
PureTech Scientific provides Glyclean® D regulatory support around the world. In the EU, the Glyclean® D products can be utilized in formulations for national registrations. The BPR process offers a transition period that supports registering new formulations using Glyclean® D. This assures that Glyclean® D formulations will have long-term sustainability, meeting modern and future regulatory requirements. Glyclean® D is currently found in formulations in Canada and many other countries worldwide.
Sustainability and regulatory longevity of Glyclean®
PureTech Scientific is the only glycolic acid supplier having or pursuing regulatory registrations globally: US EPA registration, Canada, EU BPR, GB BPR, and Korean BPR. PureTech Scientific is also the only glycolic acid manufacturer that has a dedicated technical service group supporting customers with formulation questions and regulatory needs.
PureTech Scientific, previously the Chemours Glycolic Acid Division, has 90 years of experience managing and running large volume glycolic acid production processes and a long track record of reliable supply to a wide range of customers and products. Glyclean® is an excellent alternative to traditional disinfectants facing regulatory pressure, such as quaternary ammonium compounds or quats.